UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

European journal of nuclear medicine and molecular imaging, 2009-05, Vol.36 (5), p.811-822

2009

Volltextzugriff (PDF)

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data

Alzheimer's & dementia, 2015-09, Vol.11 (9), p.1050-1068

2015

Volltextzugriff (PDF)

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

Proceedings of the National Academy of Sciences - PNAS, 2007-11, Vol.104 (48), p.19067-19072

2007

Volltextzugriff (PDF)

P4‐281: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_27), p.P1392-P1392

2019

Volltextzugriff (PDF)

IC‐P‐011: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_1), p.P20-P21

2019

Volltextzugriff (PDF)

Surgery and Brain Atrophy in Cognitively Normal Elderly Subjects and Subjects Diagnosed with Mild Cognitive Impairment

Anesthesiology (Philadelphia), 2012-03, Vol.116 (3), p.603-612

2012

Volltextzugriff (PDF)

Structural brain changes in normal individuals with a maternal history of Alzheimer's

Neurobiology of aging, 2011-12, Vol.32 (12), p.2325.e17-2325.e26

2011

Volltextzugriff (PDF)

Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology

Alzheimer's & dementia, 2019-06, Vol.15 (6), p.807-816

2019

Volltextzugriff (PDF)

P2‐427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_15), p.P775-P776

2019

Volltextzugriff (PDF)

IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_1), p.P45-P45

2019

Volltextzugriff (PDF)

O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_24), p.P1268-P1269

2019

Volltextzugriff (PDF)

Hippocampal hypometabolism predicts cognitive decline from normal aging

Neurobiology of aging, 2008-05, Vol.29 (5), p.676-692

2008

Volltextzugriff (PDF)

Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction?

The American journal of surgery, 2010-06, Vol.199 (6), p.782-788

2010

Volltextzugriff (PDF)

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

Journal of Clinical Neurology, 2009, 5(4), , pp.153-166

2009

Volltextzugriff (PDF)

P4‐178: A study of optimal SUVR cutpoints and reference regions for florbetaben PET

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_18), p.P847-P848

2015

Volltextzugriff (PDF)

COMPARISON OF 18F-FLORBETABEN QUANTIFICATION RESULTS USING MR-BASED AND MR-LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P123-P123

2017

Volltextzugriff (PDF)

P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_23), p.P1237-P1238

2018

Volltextzugriff (PDF)

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

Neurobiology of aging, 2009-05, Vol.30 (5), p.682-690

2009

Volltextzugriff (PDF)

Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders

Neurobiology of aging, 2011-12, Vol.32 (12), p.2131-2141

2011

Volltextzugriff (PDF)

Robust and Conventional Neuropsychological Norms: Diagnosis and Prediction of Age-Related Cognitive Decline

Neuropsychology, 2008-07, Vol.22 (4), p.469-484

2008

Volltextzugriff (PDF)

The age-specific comorbidity burden of mild cognitive impairment: a US claims database study

Alzheimer's research & therapy, 2023-12, Vol.15 (1), p.211-211, Article 211

2023

Volltextzugriff (PDF)

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P80-P81

2017

Volltextzugriff (PDF)

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P759-P760

2017

Volltextzugriff (PDF)

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1440-P1441

2017

Volltextzugriff (PDF)

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P155-P156

2017

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Aktive Filter

PublikationsformDissertationen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Humans
(66)
Life Sciences & Biomedicine
(65)
Neurology
(50)
Aged
(45)
Alzheimer's Disease
(44)
Neurosciences & Neurology
(44)
Female
(42)
Male
(42)
Middle Aged
(34)
Neurosciences
(28)
Biological And Medical Sciences
(26)
Aged, 80 And Over
(23)
Clinical Neurology
(22)
Magnetic Resonance Imaging
(22)
Medical Sciences
(20)
Biomarkers
(18)
Alzheimer Disease - Diagnosis
(16)
Alzheimer Disease - Diagnostic Imaging
(16)
Physical Sciences
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

P4‐281: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?

IC‐P‐011: DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F‐FLORBETABEN IMAGING?

Surgery and Brain Atrophy in Cognitively Normal Elderly Subjects and Subjects Diagnosed with Mild Cognitive Impairment

Structural brain changes in normal individuals with a maternal history of Alzheimer's

Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology

P2‐427: THE RELATIONSHIP BETWEEN HISPANIC ETHNICITY, AMYLOID LOAD AND APOE4 CARRIER STATUS

IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET

O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET

Hippocampal hypometabolism predicts cognitive decline from normal aging

Does mild cognitive impairment increase the risk of developing postoperative cognitive dysfunction?

Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies

P4‐178: A study of optimal SUVR cutpoints and reference regions for florbetaben PET

COMPARISON OF 18F-FLORBETABEN QUANTIFICATION RESULTS USING MR-BASED AND MR-LESS CAPAIBL: VALIDATION AGAINST HISTOPATHOLOGY

P3‐378: EFFECT OF AGE, GENDER, ETHNICITY, COGNITION AND APOE GENOTYPE ON AMYLOID LOAD AMONG NORMAL, MCI AND MILD DEMENTIA SUBJECTS USING [F‐18] FLORBETABEN

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders

Robust and Conventional Neuropsychological Norms: Diagnosis and Prediction of Age-Related Cognitive Decline

The age-specific comorbidity burden of mild cognitive impairment: a US claims database study

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-POSITIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY- VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

COMPARING IMAGING PHENOTYPES OF AMNESTIC EARLY VERSUS LATE-ONSET AMYLOID-NEGATIVE MILD COGNITIVE IMPAIRMENT AND DEMENTIA ADNI SUBJECTS

Aktive Filter

Suchergebnisse filtern